SPOTLIGHT -
Advice for Clinical Management of Multiple Sclerosis
Dr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.
Long-Term Outcomes With Ozanimod Based on Number of MS Relapses
A multiple sclerosis expert, Dr Darin Okuda reviews long-term outcomes with ozanimod in DAYBREAK trial based on the number of relapses that was presented at EAN 2022.
Managing Relapses in Patients With Multiple Sclerosis
Dr Darin Okuda discusses strategies for treatment selection and management of relapses in multiple sclerosis.
